Schedule 13D ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2019-08-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,359,679
- Percent of class
- 48.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-038249
- Form type
- SC 13D
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Aug 07, 2019
- Reporting period
- Aug 05, 2019
- Description
- Schedule 13D beneficial ownership